Why is Ranbaxy seeking a greater presence in the US market?
The significance of US market is that it constitutes 42 per cent of the world pharma market. Moreover, US is the single largest generic market. For all the research based companies, sixty per cent of the revenue comes from the US market. US shall continue to play an increasing role for Ranbaxy in the future also. How far has Ranbaxy been successful as a research-oriented company? Ranbaxy s emphasis has been on innovative research programmes like New Drug Discovery Research (NDDR) and Novel Drug Delivery Systems (NDDS). The company s BPH molecule is undergoing clinical trials in India. The preliminary results so far (now it is in the final stage of phase-II trials) revealed that the molecule exhibits safety, tolerance and single dose efficacy. As far as NDDS is concerned, the company s research team is currently working on eight projects, employing its proprietary platform technologies. By the end of this year we expect two drug candidates from this effort. In terms of delivery systems,
